Skip to main content

Maria del Mar Riveiro Barciela

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Maria del Mar Riveiro Barciela

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Simplification of screening and treatment of hepatitis C in immigrant population in Barcelona.

IP: Maria del Mar Riveiro Barciela
Collaborators: -
Funding agency: GILEAD SCIENCES SLU
Funding: 49494.28
Reference: GLD19-00080
Duration: 24/10/2019 - 23/07/2021

Immune profiling to guide host-directed interventions to cure HBV infections

IP: Maria Buti Ferret
Collaborators: Tamara Del Rio Higueras, Mª Eulàlia Molinas Guilera, Amaia Latasa Arrazubi, Judit Romero Vico, Maria del Mar Riveiro Barciela
Funding agency: EUROPEAN COMMISSION
Funding: 211443.8
Reference: IP-CURE-B_H2020SC1BHC2019
Duration: 01/01/2020 - 31/12/2025

Estudio prospectivo para identificar nuevos marcadores plasmáticos de replicación viral en pacientes con hepatitis crónica por virus de la hepatitis B (VHB) y/o Delta (VHD)

IP: Maria Buti Ferret
Collaborators: Maria del Mar Riveiro Barciela, Adriana Palom Agusti, Maria Francesca Cortese
Funding agency: Instituto de Salud Carlos III
Funding: 224757.5
Reference: PI17/02233
Duration: 01/01/2018 - 31/12/2021

Carotid atherosclerosis and chronic hepatitis B: role of persistent viral suppression and immunemediated response. A prospective study.

IP: Maria Buti Ferret
Collaborators: Maria del Mar Riveiro Barciela
Funding agency: GILEAD SCIENCES SLU
Funding: 49005
Reference: GLD16_00057
Duration: 14/12/2016 - 13/12/2018

Related news

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

Maria Elena Ballarin Alins

Maria Elena Ballarin Alins

Clinical Pharmacology
Read more
Camilo Andres Bonilla Rojas

Camilo Andres Bonilla Rojas

Shock, Organ Dysfunction and Resuscitation
Read more
Hugo Ramos Abellan

Hugo Ramos Abellan

Research technician
Diabetes and Metabolism
Read more
Montserrat Romero Reinaldos

Montserrat Romero Reinaldos

Research technician
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.